Gastroenterology Department

Digestive Oncology is a branded department of the University of Beijing's Cancer Hospital, dedicated to clinical research and transformation of gene-based genotypes including stomach cancer, colorectal cancer, esophageal cancer, hepatocellular pancreatic tumor, gastrointestinal prostate tumor, neural endocrine tumor, and other malignant tumors of the digestive system. It has achieved international advanced standards, is an international leader in the development of new technologies such as cancer drugs, cell therapy and other anti-tumor drugs. The team of digestive oncology is committed to the idea of precision treatment, combining disease characteristics, genotyping, molecular characteristics to evaluate patients' tumor biological features and prognostic factors, and working closely with MDT teams, research teams, breaking traditional therapeutic concepts, combining the latest scientific developments at home and abroad, combining precision treatment, multidisciplinary diagnostics, transformation research into science, for each patient system.  individualized precise treatment regimens, improved therapeutic efficiency, created healing opportunities, and improved patient survival.